Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 20;40(18):2525-2527.
doi: 10.1016/j.vaccine.2022.03.033. Epub 2022 Mar 22.

Decreasing routine vaccination rates in children in the COVID-19 era

Helena C Maltezou  1 , Snezana Medic  2 , Dimitrios C Cassimos  3 , Evgnosia Effraimidou  4 , Gregory A Poland  5
Affiliations

Decreasing routine vaccination rates in children in the COVID-19 era

Helena C Maltezou et al. Vaccine. .
No abstract available

Keywords: COVID-19; Children; Coverage rate; Global; Immunization; Routine vaccination.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Dr. Poland is the chair of a Safety Evaluation Committee for novel investigational vaccine trials being conducted by Merck Research Laboratories. Dr. Poland provides consultative advice on vaccine development to Merck & Co., Medicago, GlaxoSmithKline, Sanofi Pasteur, Johnson & Johnson/Janssen Global Services LLC, Emergent Biosolutions, Dynavax, Genentech, Eli Lilly and Company, Kentucky Bioprocessing, Bavarian Nordic, AstraZeneca, Exelixis, Regeneron, Janssen, Vyriad, Moderna, and Genevant Sciences, Inc. These activities have been reviewed by the Mayo Clinic Conflict of Interest Review Board and are conducted in compliance with Mayo Clinic Conflict of Interest policies. Dr. Poland holds patents related to vaccinia, influenza, and measles peptide vaccines. Dr. Poland has received grant funding from ICW Ventures for preclinical studies on a peptide based COVID-19 vaccine. This research has been reviewed by the Mayo Clinic Conflict of Interest Review Board and was conducted in compliance with Mayo Clinic Conflict of Interest policies. Helena C. Maltezou, Snezana Medic, Evgnosia Effraimidou and Dimitrios Cassimos have no conflict of interest to declare.

References

    1. da Silva T.M.R., de Sá A.C.M.G.N., Vieira E.W.R., Prates E.J.S., Beinner M.A., Matozinhos F.P. Number of doses of Measles-Mumps-Rubella vaccine applied in Brazil before and during the COVID-19 pandemic. BMC Infect Dis. 2021;21:1237. - PMC - PubMed
    1. Nuzhath T., Ajayi K.V., Fan Q., Hotez P., Colwell B., Callaghan T., et al. Childhood immunization during the COVID-19 pandemic in Texas. Vaccine. 2021;39(25):3333–3337. - PMC - PubMed
    1. Miretu D.G., Asfaw Z.A., Addis S.G. Impact of COVID-19 pandemic on vaccination coverage among children aged 15 to 23 months at Dessie town, Northeast Ethiopia, 2020. Hum Vaccin Immunother. 2021;17(8):2427–2436. - PMC - PubMed
    1. World Health Organization. Immunization data. Available at: https://immunizationdata.who.int/listing.html?topic=coverage&location=gl... [last accessed: March 16, 2022].
    1. World Health Organization. Immunization coverage. Available at: https://www.who.int/news-room/fact-sheets/detail/immunization-coverage [last accessed: March 16, 2022].